Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Covington
McKesson
McKinsey
QuintilesIMS
Deloitte

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pictilisib

« Back to Dashboard

US Patents for Pictilisib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pictilisib ➤ Try a Free Trial In vitro production of foregut stem cells Cambridge Enterprise Limited (GB) ➤ Try a Free Trial
Pictilisib ➤ Try a Free Trial Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
Pictilisib ➤ Try a Free Trial Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Pictilisib ➤ Try a Free Trial Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
Pictilisib ➤ Try a Free Trial Antibody drug conjugates Novartis AG (Basel, CH) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Pictilisib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Pictilisib Australia 2014333942 2033-10-09 ➤ Try a Free Trial
Pictilisib Canada 2963886 2033-10-09 ➤ Try a Free Trial
Pictilisib China 105793414 2033-10-09 ➤ Try a Free Trial
Pictilisib European Patent Office 3060652 2033-10-09 ➤ Try a Free Trial
Pictilisib United Kingdom 201317869 2033-10-09 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Daiichi Sankyo
Chubb
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: